Mary Cushman Spoke with WPTZ About New Research Showing Incidence of Cognitive Impairment Prediction
Mary Cushman, University Distinguished Professor and Vice Chair at University of Vermont, shared her first post on LinkedIn:
“My 1st LinkedIn post!
I was pleased to speak with WPTZ about our new research showing that circulating laboratory markers of neurodegeneration can predict the incidence of cognitive impairment over 12 years in initially healthy people.
It is amazing to me that damage to the brain can be detected in the blood, and detect pathology occurring years before cognitive problems start.
Associations were larger than I thought they’d be.
This research comes from the REGARDS Study, which we have been conducting since 2003.”
Title: Circulating Biomarkers of Neurodegeneration and Risk of Cognitive Impairment
Authors: Russell P. Sawyer, Aleena Bennett, Jessica Blair, Suzanne E. Judd, Nels Olson, Virginia J. Howard, Nicole D. Armstrong, D. Leann Long, Hyacinth I. Hyacinth, Jennifer J. Manly, Mary Cushman

Read full paper here.
Never miss the latest with Hemostasis Today.
-
Mar 16, 2026, 19:16Maha Othman: Delighted to See Our Article Receive The Eberhard F. Mammen Most Popular Article Award 2026
-
Mar 16, 2026, 19:03Limited Evidence for Anticoagulation Despite High VTE Risk in Sickle Cell Disease – RPTH
-
Mar 16, 2026, 18:59Bartosz Hudzik: Choosing The Right Anticoagulant for Acute Venous Thromboembolism
-
Mar 16, 2026, 18:54Michael Recht Appointed Chief Medical and Scientific Advisor to NBDF’s Pathway to Cures
-
Mar 16, 2026, 18:46David McIntosh: Moving Beyond Doubts and Ensuring the Safety of Plasma Donation
-
Mar 16, 2026, 18:42Ramy Abdelnaby: Exploring Advances in Antithrombotic Therapy for Noncardioembolic Ischemic Stroke
-
Mar 16, 2026, 18:27Christina (Tina) P: Help Advance Research and Support Patients with Antiphospholipid Syndrome
-
Mar 16, 2026, 18:20Ahmed Koriesh: Stroke Prevention in the New 2026 ACC/AHA Dyslipidemia Guideline
-
Mar 16, 2026, 18:13Nameer Ascandar: Outcomes After GI Bleeding in Patients with Rheumatoid Arthritis and AF on Long-Term Oral Anticoagulation